Effect of Somatic Mutations in Glioblastoma Multiforme on Patient Survival
AJAS · 2025 Biomedical and Health Sciences (inferred)
Overview
Glioblastoma multiforme is one of the deadliest forms of brain tumors. Many genes are associated with its formation, progression, and survival, but no consensus has been reached on which somatic mutations most significantly impact survival. This study hypothesized that patients with increased age at diagnosis, EGRF mutations, and no mutations in the IDH1, ATRX, and RB1 genes would have significantly (p ≤ 0.05) lower survival. Cox Proportional Hazards (COXPH) models are used to predict survival after diagnosis based on tumor mutational profiling. The models analyzed 499 genes and their respective somatic mutation status from 280 individuals using a derived dataset from the TCGA database of the National Cancer Institute posted on Kaggle (https://www.kaggle.com/datasets/palashio/glioblastomamutations). A univariate COXPH model was first implemented for each gene and clinical characteristic to find features that had a significant (p ≤ 0.05) effect on survival. After splitting the dataset into training and testing groups using a 70-30 split, a multivariate COXPH model was composed of 11 significant genes and 2 clinical characteristics from the univariate analysis. It was evaluated using the concordance index (0.67) and time-dependent receiver operating characteristic curves and their respective area under the curve (AUC) at 100 days (AUC=0.67), 300 days (AUC=0.74), and 500 days (AUC=0.76). The effect of each significant gene and clinical characteristic from the multivariate model was further evaluated using Kaplan-Meier curves where the effect of NLRP4 and Age at Diagnosis on survival was validated.
Competition history
- AJAS 2025
Related projects
ISEF · 2024
The Effect of Somatic Mutations in Glioblastoma Multiforme on Patient Survival
ISEF · 2021
Comparative Analysis of Genetic Mutations and Overall Survival in Patients with Glioblastoma Multiforme: A Retrospective Cohort Study
AJAS · 2022
Disease Free Months, Karnofsky Performance Score, and Sex Help Predict Glioblastoma Patient Survival
AJAS · 2020
Effect of Transcriptome Regulation on Glioblastoma Patient Survival
ISEF · 2021
Differential Expression Analysis and Transcriptomic Characterization of Glioma Progression
ISEF · 2022
Evolution of Oncogenic Signatures Within Glioblastoma Along a Spatiotemporal Axis
ISEF · 2019
An in silico Analysis of Glioblastoma Patients for the Identification of a miRNA Signature as a Diagnostic Biomarker
ISEF · 2025
Deciphering Glioblastoma Multiforme Mechanisms Using an HRASV12-Expressing Transgenic Zebrafish Model and Microglia Interactions
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: AAAS Annual Meeting (Confex) / American Junior Academy of Science